Alder Biopharma
(ALDR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALDR | AZN | AMGN | GILD | VRTX |
| Company | Alder Biopharma | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 18.95 | 93.37 | 341.66 | 139.75 | 479.03 |
| High | 19.12 | 93.53 | 347.27 | 140.51 | 484.35 |
| Low | 18.83 | 92.67 | 338.75 | 138.23 | 473.86 |
| Latest | 18.88 | 92.64 | 343.25 | 139.65 | 476.13 |
| Change | -0.04 | -0.58 | +1.03 | -0.07 | -1.78 |
| % Change | -0.21% | -0.62% | +0.30% | -0.05% | -0.37% |
| Volume | 29,121,700 | 5,762,406 | 1,422,443 | 4,353,566 | 988,707 |
| 20-Day Average Volume | 5,270,225 | 9,232,329 | 2,599,847 | 7,282,792 | 1,477,489 |
| Previous Close | 18.92 | 93.22 | 342.22 | 139.72 | 477.91 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.86 | 93.38 | 334.85 | 127.14 | 461.45 |
| 20-Day Raw Stochastic | 48.94% | 52.88% | 74.91% | 90.58% | 79.58% |
| 20-Day Relative Strength | 79.65 | 52.22 | 57.77 | 67.13 | 59.16 |
| Weighted Alpha | -4.50 | +34.56 | +24.44 | +46.49 | +8.48 |
| Today's Opinion | 88% Buy | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 88% Buy | 88% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 24% Buy | 100% Buy | 96% Buy | 80% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.21% since 10/14/19 | +1.42% since 01/22/26 | -0.75% since 01/22/26 | +6.28% since 01/22/26 | +1.76% since 01/22/26 |
| Low | 18.83 on 10/21/19 | 91.44 on 01/23/26 | 338.75 on 01/29/26 | 131.00 on 01/23/26 | 462.73 on 01/23/26 |
| High | 19.12 on 10/21/19 | 96.18 on 01/27/26 | 353.25 on 01/27/26 | 141.71 on 01/27/26 | 485.00 on 01/27/26 |
| 1-Month | |||||
| %Chg | +1.29% since 09/20/19 | +0.51% since 12/29/25 | +4.50% since 12/29/25 | +11.58% since 12/29/25 | +3.43% since 12/29/25 |
| Low | 18.60 on 09/23/19 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 19.12 on 10/21/19 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.71 on 01/27/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +92.26% since 07/19/19 | +13.09% since 10/29/25 | +18.06% since 10/29/25 | +17.61% since 10/29/25 | +13.99% since 10/29/25 |
| Low | 8.39 on 09/09/19 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 403.16 on 11/04/25 |
| High | 19.12 on 10/21/19 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.71 on 01/27/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +48.90% since 04/18/19 | +25.70% since 07/29/25 | +13.47% since 07/29/25 | +22.01% since 07/29/25 | +1.53% since 07/29/25 |
| Low | 8.39 on 09/09/19 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 19.12 on 10/21/19 | 96.51 on 01/07/26 | 353.25 on 01/27/26 | 141.71 on 01/27/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,582,842 | 289,151,296 | 184,278,976 | 173,347,824 | 121,254,848 |
| Shares Outstanding, K | 83,837 | 3,101,816 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -296,430,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | N/A | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | N/A | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 2.64 | 0.34 | 0.45 | 0.33 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 1.19 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/04/19 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.92 | 16.06 | 17.21 | 30.97 |